Tirzepatide (LY3298176) Testing & Verification
Independent, third-party analysis of mail-in tirzepatide samples by RP-HPLC-UV — confirming what your vial actually contains, not what the label claims, against a certified reference standard.
What Tirzepatide is
Tirzepatide, development code LY3298176, is a synthetic 39-amino-acid peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It is built on a GIP-based backbone with unnatural residues (including Aib substitutions) and carries a C20 fatty-diacid side chain conjugated through a linker to a lysine — an acylation that gives it a molecular weight near 4,813 g/mol. The combination of a long synthetic sequence, non-coded residues, and a covalent lipid chain makes it demanding to synthesize reproducibly. Material on the research-chemical market is sold as a lyophilized powder with no regulated manufacturing or identity guarantee, separate from any approved finished product, which is why independent verification is worthwhile.
Why get your Tirzepatide independently tested
- Wrong-compound substitution: tirzepatide, semaglutide, and retatrutide are all lipidated GLP-class peptides indistinguishable by eye. Because they differ substantially in price, there is incentive to substitute or mislabel — an identity check by retention-time and UV-spectral match against a certified tirzepatide reference standard confirms the vial actually holds tirzepatide.
- Acylation integrity: the C20 fatty-diacid side chain is central to tirzepatide's identity. A des-acyl or truncated backbone elutes differently on reversed-phase HPLC, so identity testing flags material missing its lipid modification.
- Net-peptide content vs. label: lyophilized vials include counter-ion salt, residual moisture, and bulking agent on top of peptide. A net-peptide assay reports the actual milligrams of tirzepatide per vial, so a measured value can be compared against the labeled amount.
- Synthesis-related impurities: the long acylated sequence with unnatural residues is prone to truncated and deletion-sequence by-products and incomplete side-chain conjugation. Chromatographic purity as area percent quantifies how much of the UV-absorbing material is the target peak versus everything else.
What we measure on Tirzepatide
Every tirzepatide sample is run by reversed-phase HPLC with UV/diode-array detection at 214 nm against a certified reference standard. Each certificate reports exactly three results: identity (retention-time plus UV-spectral match to the reference), chromatographic purity as area percent of the main peak, and net-peptide assay as milligrams of peptide per vial. Together these answer whether the material is tirzepatide, how clean it is, and how much peptide is actually present.
Every result is issued as a certificate of analysis you — or anyone you forward it to — can verify cryptographically. Reporting identity, purity, and milligram content is the point: a vial can be pure and still underfilled, so we report all three. More on purity vs. net-peptide content and how to read a peptide COA.
Our scope — stated plainly
Testing is RP-HPLC-UV against a certified reference standard, not mass spectrometry — identity is a retention-time and UV-spectral match rather than a direct mass measurement. Tirzepatide reference standards are commercially available, so identity testing does not usually require a sourcing delay. KMD Analytical is an independent laboratory; we do not perform sterility, endotoxin, heavy-metal, or residual-solvent testing.
KMD is an independent RP-HPLC-UV lab. We do not run LC-MS / mass-spec, sterility, endotoxin, or heavy-metal testing. If your job needs a capability we don't have, we'll say so.
Tirzepatide testing — FAQ
Can you tell tirzepatide apart from semaglutide or retatrutide?
Yes. Each is a distinct lipidated peptide with its own retention time and UV spectrum under our RP-HPLC-UV method. Comparing your sample against a certified tirzepatide reference standard confirms whether the material matches tirzepatide or is a different GLP-class analog. This is a retention-time and UV-spectral match, not a mass-spectrometry sequence confirmation.
Does the net-peptide assay tell me the actual amount in my vial?
It reports the milligrams of net peptide measured in the sample you send, which you can compare against the labeled quantity. It measures peptide content specifically, excluding salt, counter-ion, and excipient mass that can otherwise inflate a vial's apparent weight.
Do you run mass spectrometry to confirm the sequence?
No. We verify identity by retention-time and UV-spectral match against a certified reference standard using RP-HPLC-UV, not by mass spectrometry, and we do not perform sterility, endotoxin, heavy-metal, or residual-solvent testing.
Other peptides we test
Retatrutide · Cagrilintide · Tesamorelin · BPC-157 · see the full panel.